{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:08:15Z","timestamp":1793768895360,"version":"4.6.1"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pituitary adenomas (PAs) have been shown to cause excess cardiovascular disease comorbidity and mortality. Cerebrovascular disease (CeVD) is a small subset of cardiovascular disease with high morbidity, and its risk in patients with pituitary adenomas has been sparingly explored. In this review, we examine what is known about the prevalence of cerebrovascular disease in patients with PAs, from its initial discovery in 1970 to present. An abundance of literature describes increased cerebrovascular mortality in patients with acromegaly, while research on other PA subtypes is less frequent but shows a similarly elevated CeVD mortality relative to healthy populations. We also review how cerebrovascular risk changes after PAs are treated, with PA treatment appearing to prevent further accumulation of cerebrovascular risk without reversing prior elevations. While acromegaly-associated CeVD appears to be\u00a0caused by elevated growth hormone (GH) levels and Cushing disease\u2019s elevated glucocorticoids similarly cause durable alterations in cerebrovascular structure and function, less is known about the mechanisms behind CeVD in other PA subpopulations. Proposed pathophysiologies include growth hormone deficiency inducing vessel wall damage or other hormone deficits causing increased atherosclerotic disease. Early diagnosis and treatment of PAs may be the key to minimizing lifetime CeVD risk elevations. More research is needed to better understand the mechanisms behind the increased CeVD seen in patients with PAs. Physicians caring for PA patients must remain vigilant for signs and symptoms of cerebrovascular disease in this patient population.<\/jats:p>","DOI":"10.3389\/fendo.2022.1064216","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:12:30Z","timestamp":1670825550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Pituitary adenomas and cerebrovascular disease: A review on pathophysiology, prevalence, and treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Robert C.","family":"Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Y.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeki","family":"Lad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3171\/2014.5.JNS131819","article-title":"Descriptive epidemiology of pituitary tumors in the United States 2004\u20132009: Clinical article","volume":"121","author":"Gittleman","year":"2014","journal-title":"J Neurosurg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0889-8529(18)30474-2","article-title":"Nonsecreting pituitary tumors","volume":"16","author":"Klibanski","year":"1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in northern Finland in 1992\u20132007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: A cross-sectional study in the province of li\u00e8ge, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30185-3","article-title":"Clinically nonfunctioning pituitary adenomas","volume":"22","author":"Snyder","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36708","article-title":"Gonadotropinomas","volume":"20","author":"Chaidarun","year":"2002","journal-title":"Semin Reprod Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102283240909","article-title":"Gonadotroph-cell pituitary adenomas","volume":"324","author":"Molitch","year":"1991","journal-title":"N Engl J Med"},{"key":"B11","article-title":"Pituitary adenomas: An overview","volume":"88","author":"Lake","year":"2013","journal-title":"afp"},{"key":"B12","unstructured":"What is cardiovascular disease"},{"key":"B13","doi-asserted-by":"publisher","first-page":"vdab136","DOI":"10.1093\/noajnl\/vdab136","article-title":"Raised cardiovascular disease mortality after central nervous system tumor diagnosis: Analysis of 171,926 patients from UK and USA","volume":"3","author":"Jin","year":"2021","journal-title":"Neurooncol Adv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1420","article-title":"Pituitary adenomas in Sweden between 1958 and 1991: Incidence, survival, and mortality","volume":"85","author":"Nilsson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1507\/endocrj.EJ20-0185","article-title":"Silent pituitary adenoma and metabolic disorders: Obesity, abnormal glucose tolerance, hypertension and dyslipidemia","volume":"68","author":"Baba","year":"2021","journal-title":"Endocrine J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1172-7-41","article-title":"Cushing\u2019s disease","volume":"7","author":"Castinetti","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0122","article-title":"Evaluation of cardiovascular risk with arterial stiffness in patients with nonfunctioning pituitary adenoma","volume":"24","author":"\u00c7a\u011f\u0131r","year":"2018","journal-title":"Endocrine Practice"},{"key":"B18","unstructured":"Cerebrovascular disease \u2013 classifications, symptoms, diagnosis and treatments"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11102-020-01084-6","article-title":"Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: A nationwide population-based study","volume":"24","author":"Oh","year":"2021","journal-title":"Pituitary."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: Review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e159","article-title":"Descriptive epidemiology and survival analysis of acromegaly in Korea","volume":"36","author":"Yun","year":"2021","journal-title":"J Korean Med Sci"},{"key":"B23","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","author":"Wright","year":"1970","journal-title":"Q J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","article-title":"Epidemiology of acromegaly in the Newcastle region","volume":"12","author":"Alexander","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"Epidemiology and long-term survival in acromegaly: A study of 166 cases diagnosed between 1955 and 1984","volume":"223","author":"Bengtsson","year":"1988","journal-title":"Acta Med Scandinavica"},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.8.2730","article-title":"Mortality and cancer incidence in acromegaly: A retrospective cohort study. United Kingdom acromegaly study group","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly","volume":"90","author":"Kauppinen-M\u00e4kelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B32","article-title":"Intracerebral hemorrhage revealing a cushing\u2019s disease","volume":"5","author":"Chauveau","year":"2015","journal-title":"Am J Cardiovasc Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jc.2008-1346","article-title":"Extensive and largely reversible ischemic cerebral infarctions in a prepubertal child with hypertension and cushing disease","volume":"94","author":"Nguyen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/000331979604701010","article-title":"Risk factors for brain infarction in patients with cushing\u2019s disease","volume":"47","author":"Mizokami","year":"1996","journal-title":"Case Rep Angiology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in cushing\u2019s syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"dgaa291","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess morbidity persists in patients with cushing\u2019s disease during long-term remission: A Swedish nationwide study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with cushing disease: A Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"B\u00fclow","year":"1997","journal-title":"Clin Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1475","article-title":"Excess mortality in women and young adults with nonfunctioning pituitary adenoma: A Swedish nationwide study","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-16-0173","article-title":"Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: A Swedish nationwide study","volume":"175","author":"Olsson","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.07.004","article-title":"Cerebrovascular disease in patients with pituitary tumors","volume":"16","author":"Erfurth","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ghir.2019.01.002","article-title":"IGF-1 and cardiovascular disease","volume":"45","author":"Higashi","year":"2019","journal-title":"Growth Horm IGF Res"},{"key":"B46","article-title":"The effect of endocrine disorders on lipids and lipoproteins","volume-title":"Endotext","author":"Feingold","year":"2000"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1042\/CS20050281","article-title":"Endothelial dysfunction in growth hormone transgenic mice","volume":"110","author":"Andersson","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-007-9067-8","article-title":"Does acromegaly enhance mortality","volume":"9","author":"Ayuk","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in cushing\u2019s syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/me.2008-0464","article-title":"Direct effect of glucocorticoids on lipolysis in adipocytes","volume":"23","author":"Xu","year":"2009","journal-title":"Mol Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.8.5896","article-title":"Persistence of increased cardiovascular risk in patients with cushing\u2019s disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1159\/000318566","article-title":"Cardiovascular disease in cushing\u2019s syndrome: Heart versus vasculature","volume":"92","author":"Leo","year":"2010","journal-title":"NEN"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1588","article-title":"Hypertrophic remodeling of subcutaneous small resistance arteries in patients with cushing\u2019s syndrome","volume":"94","author":"Rizzoni","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000226182.60321.69","article-title":"Role of the renin\u2013angiotensin\u2013aldosterone system in vascular remodeling and inflammation: a clinical review","volume":"24","author":"Duprez","year":"2006","journal-title":"J Hypertension"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.10.2.237","article-title":"Effects of cortisone, hydrocortisone and corticotropin on lipemia, glycemia and atherogenesis in cholesterol-fed chicks","volume":"10","author":"Stamler","year":"1954","journal-title":"Circulation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-009-9295-7","article-title":"The relationship between aortic stiffness and left ventricular function in patients with cushing\u2019s disease: aortic stiffness in cushing\u2019s disease","volume":"37","author":"Bayram","year":"2010","journal-title":"Endocrine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12524","article-title":"Enhanced oxidative stress and platelet activation in patients with cushing\u2019s syndrome","volume":"82","author":"Karamouzis","year":"2015","journal-title":"Clin Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490549","article-title":"Elevated plasma endothelin as an additional cardiovascular risk factor in patients with cushing\u2019s syndrome","volume":"149","author":"Kirilov","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.751743","article-title":"Cushing\u2019s disease: Assessment of early cardiovascular hemodynamic dysfunction with impedance cardiography","volume":"12","author":"Jurek","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.07.006","article-title":"Hypertension in cushing\u2019s syndrome","volume":"20","author":"Magiakou","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02297-2","article-title":"Cardiovascular and metabolic risk factors in patients with subclinical cushing","volume":"70","author":"Petramala","year":"2020","journal-title":"Endocrine"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-992813","article-title":"Circadian blood pressure profile in patients with active cushing\u2019s disease and after long-term cure","volume":"39","author":"Pecori Giraldi","year":"2007","journal-title":"Horm Metab Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00702-6","article-title":"Covert actions of growth hormone: Fibrosis, cardiovascular diseases and cancer","volume":"18","author":"Kopchick","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0370","article-title":"Comorbidities in patients with non-functioning pituitary adenoma: Influence of long-term growth hormone replacement","volume":"179","author":"Hammarstrand","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glq147","article-title":"Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats","volume":"65","author":"Ungvari","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin-resistant","volume":"44","author":"Johansson","year":"1995","journal-title":"Metab - Clin Experimental"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.2.5456","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient Adults1","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.2.6346","article-title":"Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors","volume":"85","author":"B\u00fclow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0599","article-title":"Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis","volume":"165","author":"Verhelst","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.5.3951","article-title":"Increased arterial intima-media thickness in childhood-onset growth hormone deficiency","volume":"82","author":"Capaldo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e2109600118","DOI":"10.1073\/pnas.2109600118","article-title":"Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke","volume":"118","author":"Liu","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B74","doi-asserted-by":"publisher","first-page":"E256","DOI":"10.3390\/ijms22010256","article-title":"Neuroprotective effects of growth hormone (GH) and insulin-like growth factor type 1 (IGF-1) after hypoxic-ischemic injury in chicken cerebellar cell cultures","volume":"22","author":"Baltazar-Lara","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.3390\/ijms23169054","article-title":"Neuroprotective and regenerative effects of growth hormone (GH) in the embryonic chicken cerebral pallium exposed to hypoxic-ischemic (HI) injury","volume":"23","author":"Olivares-Hern\u00e1ndez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"E807","DOI":"10.3390\/cells9040807","article-title":"Why should growth hormone (GH) be considered a promising therapeutic agent for arteriogenesis? Insights from the GHAS trial","volume":"9","author":"Caicedo","year":"2020","journal-title":"Cells."},{"key":"B77","doi-asserted-by":"publisher","first-page":"E606","DOI":"10.3390\/ijms21020606","article-title":"Growth hormone promotes motor function after experimental stroke and enhances recovery-promoting mechanisms within the peri-infarct area","volume":"21","author":"Sanchez-Bezanilla","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02583.x","article-title":"The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism","volume":"41","author":"Toogood","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/BF02112028","article-title":"Bonicki W, kasperlik-za\u0142uska a, koszewski W, zgliczy\u0144ski W, wis\u0142awski j. pituitary apoplexy: endocrine, surgical and oncological emergency. incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas","volume":"120","year":"1993","journal-title":"Acta Neurochir (Wien)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283319061","article-title":"Pituitary apoplexy: Evaluation, management, and prognosis","volume":"20","author":"Murad-Kejbou","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/25046.9782","article-title":"Acute ischaemic stroke as a manifestation of pituitary apoplexy in a young lady","volume":"11","author":"Pasha","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2008.23.6.1113","article-title":"Pituitary apoplexy producing internal carotid artery compression: a case report","volume":"23","author":"Yang","year":"2008","journal-title":"J Korean Med Sci"},{"key":"B83","article-title":"Massive cerebral infarction as a feature of pituitary apoplexy","volume":"49","author":"Lath","year":"2001","journal-title":"Neurol India"},{"key":"B84","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25259\/SNI_82_2020","article-title":"Pituitary apoplexy causing acute ischemic stroke: Which treatment should be given priority","volume":"11","author":"Ahn","year":"2020","journal-title":"Surg Neurol Int"},{"key":"B85","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"2007 GH deficiency consensus workshop participants. consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: A statement of the GH research society in association with the European society for pediatric endocrinology, Lawson Wilkins society, European society of endocrinology, Japan endocrine society, and endocrine society of Australia","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","first-page":"85","article-title":"Replacement therapy and cardiovascular diseases","volume":"31","author":"Boschetti","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch national registry of growth hormone treatment in adults","volume":"96","author":"van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0458","article-title":"Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone","volume":"92","author":"Holmer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030876","article-title":"An epidemiologist looks at hormones and heart disease in women","volume":"88","author":"Barrett-Connor","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The women\u2019s health initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2415","article-title":"Update in mortality in GH-treated patients","volume":"98","author":"Erfurth","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1064216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:12:36Z","timestamp":1670825556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1064216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":93,"alternative-id":["10.3389\/fendo.2022.1064216"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1064216","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"article-number":"1064216"}}